» Articles » PMID: 38994777

Increasing Prevalence of Cerebral Palsy in Children Born Very Preterm in Denmark

Overview
Date 2024 Jul 12
PMID 38994777
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To analyse the rising prevalence of cerebral palsy (CP) in children born preterm in Denmark.

Method: We included all live-born children born preterm in Denmark from 1997 to 2013. The prevalence of CP in children born preterm was categorized by gestational age and correlated with neonatal mortality and changes in clinical factors.

Results: Among 70 876 children, 824 (1.2%) had CP. The overall CP prevalence in children born preterm decreased substantially until 2001, from when it increased annually by 2.8% (95% confidence interval 0.6-5.0). When categorized, the prevalence only increased significantly in children born very preterm (gestational weeks 28-31). Neonatal mortality rates decreased steadily at all gestational ages during the entire study period. Clinical factors that changed during the study period were increasing numbers of high-risk pregnancies, maternal obesity, emergency caesarean sections, neonatal admissions, and usage of assisted ventilation.

Interpretation: The increasing prevalence of CP in children born preterm was driven by the subgroup born very preterm and matched their decrease in neonatal mortality. In similar population studies, decreased mortality was not followed by increased CP prevalence. An increase in clinical risk factors was unlikely to explain our findings, but more active neonatal life support may have played a role.

Citing Articles

A global picture of outcomes after preterm birth: Is there a discrepancy?.

Morgan A Dev Med Child Neurol. 2024; 67(1):8-9.

PMID: 39255389 PMC: 11625464. DOI: 10.1111/dmcn.16092.


Increasing prevalence of cerebral palsy in children born very preterm in Denmark.

Fogh M, Greisen G, Clausen T, Krebs L, Larsen M, Hoei-Hansen C Dev Med Child Neurol. 2024; 67(1):68-76.

PMID: 38994777 PMC: 11625462. DOI: 10.1111/dmcn.16020.

References
1.
Himmelmann K, Pahlman M . The panorama of cerebral palsy in Sweden part XIII shows declining prevalence in birth-years 2011-2014. Acta Paediatr. 2022; 112(1):124-131. PMC: 10092185. DOI: 10.1111/apa.16548. View

2.
Gatman K, May R, Crowther C . Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand - Ongoing barriers and enablers. Aust N Z J Obstet Gynaecol. 2019; 60(1):44-48. DOI: 10.1111/ajo.12981. View

3.
Nyboe Andersen A . [In vitro fertilisation during 40 years]. Ugeskr Laeger. 2021; 183(48). View

4.
Wolf H, Brok J, Henriksen T, Greisen G, Salvig J, Pryds O . Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial. BJOG. 2020; 127(10):1217-1225. DOI: 10.1111/1471-0528.16239. View

5.
Barrington K . The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr. 2001; 1:1. PMC: 29104. DOI: 10.1186/1471-2431-1-1. View